✦ LIBER ✦

Interferon alpha and doxorubicin in malignant mesothelioma: a phase II study

✍ Scribed by Upham, J.W. ;Musk, A.W. ;Hazel, G. ;Byrne, M. ;Robinson, B.W.S.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

265 A phase II study of doxorubicin and

✍ Penson, R.T.; Mulatero, C.W.; Gower, N.H.; Evans, M.T.; Rudd, R.M. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 305 KB

Phase I study of combined alpha Interfer

✍ Vinod Ganju; John H. Edmonson; Jan C. Buckner 📂 Article 📅 1994 🏛 Springer US 🌐 English ⚖ 260 KB

Ifosfamide in malignant mesothelioma: a

✍ Andersen, M 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 69 KB

Treatment of malignant pleural mesotheli

✍ Mattson, K.; Halme, M.; Salminen, U-S.; Pyrhönen, S.; Tammilehto, L.; Maasilta, 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 144 KB

202 Combination chemotherapy with methot

✍ Kuribayashi, K.; Fukuoka, K.; Miyake, M.; Miyata, S.; Nakajima, T.; Tamura, K.; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 37 KB

A phase II trial of ifosfamide/mesna wit

✍ Carmichael, James; Cantwell, Brian M.J.; Harris, Adrian L. 📂 Article 📅 1989 🏛 Elsevier Science ⚖ 172 KB